Physician profile
Bilal Master
NPI 1588156756
$3,739.48
in general payments reported to CMS, 2019-2025
18 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2022: $277 · 2023: $1,125 · 2024: $559 · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,747 · Travel and Lodging: $265 · Long Term Medical Supply Or Device Loan: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,747.44 |
| Travel and Lodging | $264.71 |
| Long Term Medical Supply Or Device Loan | $146.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medinc of Texas | $1,304.00 | 2019 | |
| Medline Industries Lp | $554.95 | 2023 | |
| Stryker Corporation | $390.03 | 2022-2025 | Dart-Fire, Augment Injectable, Citrefix |
| Averitas Pharma INC. | $213.84 | 2023-2025 | Qutenza |
| Abbvie INC. | $196.83 | 2022-2025 | |
| Paratek Pharmaceuticals, INC. | $186.72 | 2022-2025 | Nuzyra |
| Integra Lifesciences Corporation | $146.68 | 2024 | Acell |
| Smith+Nephew, INC. | $144.92 | 2022-2025 | Hat-Trick, Collagenase Santyl, Renasys Touch |
| Reapplix INC. | $128.08 | 2023 | 3c Patch Kit - Box |
| Kerecis Limited | $97.61 | 2022-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Horizon Therapeutics Plc | $81.24 | 2022-2023 | Krystexxa |
| Amgen INC. | $73.08 | 2024 | Krystexxa |
| Innovation Technologies INC | $58.59 | 2023-2025 | Irrisept |
| Mimedx Group, INC. | $52.49 | 2024 | |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $44.97 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organogenesis INC. | $38.04 | 2023 | Puraply |
| Nevro Corp. | $14.01 | 2023 | Senza |
| Nuo Therapeutics | $13.40 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bilal Master listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.